CEO, Calla Lily Clinical Care
Thang co-founded Callaly, a period care brand which invented, developed and manufactures the Tampliner®. Now his team is taking their robustly patented technology into the drug delivery space. Their new leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs is initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Our platform has further applications being developed in the HRT / menopause market.